{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:19:23Z","timestamp":1786119563905,"version":"build-2736575974"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1097\/mjt.0b013e3181ea7821","type":"journal-article","created":{"date-parts":[[2010,9,15]],"date-time":"2010-09-15T06:53:21Z","timestamp":1284533601000},"page":"476-486","source":"Crossref","is-referenced-by-count":49,"title":["A Review of Granisetron, 5-Hydroxytryptamine3 Receptor Antagonists, and Other Antiemetics"],"prefix":"10.1097","volume":"17","author":[{"given":"Eric S","family":"Hsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-6-20210202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2007.01.028","article-title":"The neuronal 5-HT3 receptor network after 20 years of research-evolving concepts in management of pain and inflammation.","volume":"560","author":"Faerber","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"R7-6-20210202","first-page":"RA322","article-title":"Cytochrome P450 2D6 metabolism and 5-hydroxytryptamine type 3 receptor antagonists for postoperative nausea and vomiting.","volume":"11","author":"Janicki","year":"2005","journal-title":"Med Sci Monit"},{"key":"R8-6-20210202","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1188\/07.CJON.809-813","article-title":"Is ondansetron more effective than granisetron for chemotherapy-induced nausea and vomiting? A review of comparative trials.","volume":"11","author":"Vrabel","year":"2007","journal-title":"Clin J Oncol Nurs"},{"key":"R9-6-20210202","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1177\/1078155207078137","article-title":"Management of platinum-based chemotherapy-induced acute nausea and vomiting: is there a superior serotonin receptor antagonist?","volume":"13","author":"Hamadani","year":"2007","journal-title":"J Oncol Pharm Pract"},{"key":"R10-6-20210202","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/07357900701208709","article-title":"Tropisetron, ondansetron, and granisetron for control of chemotherapy-induced emesis in Turkish cancer patients: a comparison of efficacy, side-effect profile, and cost.","volume":"25","author":"Abali","year":"2007","journal-title":"Cancer Invest"},{"key":"R11-6-20210202","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s00520-006-0186-7","article-title":"A meta-analysis comparing the efficacy of four 5-HT3-receptor antagonists for acute chemotherapy-induced emesis.","volume":"15","author":"Jordan","year":"2007","journal-title":"Support Care Cancer"},{"key":"R12-6-20210202","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S1470-2045(08)70313-9","article-title":"Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomized, comparative phase III trial.","volume":"10","author":"Saito","year":"2009","journal-title":"Lancet Oncol"},{"key":"R13-6-20210202","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1213\/ane.0b013e318172fa74","article-title":"Palonosetron exhibits unique molecular interactions with the 5-HT3 receptor.","volume":"107","author":"Rojas","year":"2008","journal-title":"Anesth Analg"},{"key":"R14-6-20210202","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1213\/01.ane.0000200364.55798.3f","article-title":"Prevention of postoperative nausea and vomiting with granisetron and dolasetron in relation to CYP2D6 genotype.","volume":"102","author":"Janicki","year":"2006","journal-title":"Anesth Analg"},{"key":"R15-6-20210202","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jclinane.2007.04.006","article-title":"Preemptive antiemesis in patients undergoing modified radical mastectomy: oral granisetron versus oral ondansetron in a double-blind, randomized, controlled study.","volume":"19","author":"Bhatnagar","year":"2007","journal-title":"J Clin Anesth"},{"key":"R16-6-20210202","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/ANA.0b013e3181a7beaa","article-title":"A randomized, double-blinded comparison of ondansetron, granisetron, and placebo for prevention of postoperative nausea and vomiting after supratentorial craniotomy.","volume":"21","author":"Jain","year":"2009","journal-title":"J Neurosurg Anesthesiol"},{"key":"R17-6-20210202","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1213\/01.ane.0000208967.94601.cd","article-title":"The use of oral granisetron versus intravenous ondansetron for antiemetic prophylaxis in patients undergoing laparoscopic surgery: the effect on emetic symptoms and quality of recovery.","volume":"102","author":"White","year":"2006","journal-title":"Anesth Analg"},{"key":"R18-6-20210202","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1213\/01.ane.0000253036.06307.5c","article-title":"Prophylactic granisetron does not prevent postdelivery nausea and vomiting during elective cesarean delivery under spinal anesthesia.","volume":"104","author":"Balki","year":"2007","journal-title":"Anesth Analg"},{"key":"R19-6-20210202","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1213\/01.ane.0000261474.85547.8b","article-title":"Granisetron versus ondansetron treatment for breakthrough postoperative nausea and vomiting after prophylactic ondansetron failure: a pilot study.","volume":"104","author":"Candiotti","year":"2007","journal-title":"Anesth Analg"},{"key":"R20-6-20210202","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s12630-009-9175-x","article-title":"Double-blind comparison of granisetron, promethazine, or a combination of both for the prevention of postoperative nausea and vomiting in females undergoing outpatient laparoscopies.","volume":"56","author":"Gan","year":"2009","journal-title":"Can J Anaesth"},{"key":"R21-6-20210202","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1089\/lap.2006.0243","article-title":"Comparison of the effectiveness of metoclopramide, ondansetron, and granisetron on the prevention of nausea and vomiting after laparoscopic cholecystectomy.","volume":"17","author":"Oksuz","year":"2007","journal-title":"J Laparoendosc Adv Surg Tech A"},{"key":"R22-6-20210202","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1590\/S0034-70942008000100005","article-title":"Prophylactic antiemetic therapy for acute abdominal surgery. A comparative study of droperidol, metoclopramide, tropisetron, granisetron and dexamethasone.","volume":"58","author":"Contreras-Dominguez","year":"2008","journal-title":"Rev Bras Anestesiol"},{"key":"R23-6-20210202","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2174\/157488608783333934","article-title":"The benefits and risks of different therapies in preventing postoperative nausea and vomiting in patients undergoing thyroid surgery.","volume":"3","author":"Fujii","year":"2008","journal-title":"Curr Drug Saf"},{"key":"R24-6-20210202","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2174\/157488607779315381","article-title":"Prevention of emetic episodes during cesarean delivery performed under regional anesthesia in parturients.","volume":"2","author":"Fujii","year":"2007","journal-title":"Curr Drug Saf"},{"key":"R25-6-20210202","doi-asserted-by":"crossref","first-page":"230","DOI":"10.2174\/157488608785699423","article-title":"Clinical strategies for preventing postoperative nausea and vomiting after middle ear surgery in adult patients.","volume":"3","author":"Fujii","year":"2008","journal-title":"Curr Drug Saf"},{"key":"R26-6-20210202","doi-asserted-by":"crossref","first-page":"62","DOI":"10.2174\/157488609787354413","article-title":"Current management of vomiting after tonsillectomy in children.","volume":"4","author":"Fujii","year":"2009","journal-title":"Curr Drug Saf"},{"key":"R27-6-20210202","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.2217\/14622416.9.8.1027","article-title":"Investigation of HTR3C mutations for association with 5HT (3) receptor antagonist anti-emetic efficacy.","volume":"9","author":"Ward","year":"2008","journal-title":"Pharmacogenomics"},{"key":"R28-6-20210202","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/01.aco.0000247340.61815.38","article-title":"Pharmacology, pharmacogenetics, and clinical efficacy of 5-hydroxytryptamine type 3 receptor antagonists for postoperative nausea and vomiting.","volume":"19","author":"Ho","year":"2006","journal-title":"Curr Opin Anaesthesiol"},{"key":"R29-6-20210202","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1213\/01.ane.0000289636.09841.bc","article-title":"Premedication with mirtazapine reduces preoperative anxiety and postoperative nausea and vomiting.","volume":"106","author":"Chen","year":"2008","journal-title":"Anesth Analg"},{"key":"R30-6-20210202","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1213\/00000539-200206000-00033","article-title":"Ondansetron inhibits the analgesic effects of tramadol: a possible 5-HT (3) spinal receptor involvement in acute pain in humans.","volume":"94","author":"Arcioni","year":"2002","journal-title":"Anesth Analg"},{"key":"R31-6-20210202","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/1078155209104063","article-title":"Pharmacokinetics of a granisetron transdermal system for the treatment of chemotherapy-induced nausea and vomiting.","volume":"15","author":"Howell","year":"2009","journal-title":"J Oncol Pharm Pract"},{"key":"R32-6-20210202","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/bja\/aep125","article-title":"Neurokinin-1 receptor antagonists in the prevention of postoperative nausea and vomiting.","volume":"103","author":"Diemunsch","year":"2009","journal-title":"Br J Anaesth"},{"key":"R33-6-20210202","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1470-2045(09)70109-3","article-title":"Efficacy and safety of casopitant mesylate, a neurokinin 1 (NK1)-receptor antagonist, in prevention of chemotherapy-induced nausea and vomiting in patients receiving cisplatin-based highly emetogenic chemotherapy: a randomized, double-blind, placebo-controlled trial.","volume":"10","author":"Grunberg","year":"2009","journal-title":"Lancet Oncol"},{"key":"R34-6-20210202","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/ACO.0b013e328301831c","article-title":"The role of neurokinin-1 receptor antagonists for the management of postoperative nausea and vomiting.","volume":"21","author":"Apfel","year":"2008","journal-title":"Curr Opin Anaesthesiol"},{"key":"R35-6-20210202","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1093\/bja\/aep014","article-title":"P6 acustimulation effectively decreases postoperative nausea and vomiting in high-risk patients.","volume":"102","author":"Frey","year":"2009","journal-title":"Br J Anaesth"},{"key":"R36-6-20210202","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1213\/ane.0b013e31816d1864","article-title":"P6 stimulation for the prevention of nausea and vomiting associated with cesarean delivery under neuraxial anesthesia: a systematic review of randomized controlled trials.","volume":"107","author":"Allen","year":"2008","journal-title":"Anesth Analg"},{"issue":"Suppl 3","key":"R37-6-20210202","first-page":"1","article-title":"Cannabinoids in the treatment of chemotherapy-induced nausea and vomiting: beyond prevention of acute emesis.","volume":"5","author":"Slatkin","year":"2007","journal-title":"J Support Oncol"},{"key":"R38-6-20210202","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1634\/theoncologist.12-9-1143","article-title":"Guidelines for antiemetic treatment of chemotherapy-induced nausea and vomiting: past, present, and future recommendations.","volume":"12","author":"Jordan","year":"2007","journal-title":"Oncologist"},{"key":"R39-6-20210202","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1097\/00000542-200203000-00033","article-title":"Practice guidelines for postanesthetic care.","volume":"96","year":"2002","journal-title":"Anesthesiology"},{"key":"R41-6-20210202","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1213\/ane.0b013e31817b842c","article-title":"The impact of current antiemetic practices on patient outcomes: a prospective study on high-risk patients.","volume":"107","author":"White","year":"2008","journal-title":"Anesth Analg"}],"container-title":["American Journal of Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MJT.0b013e3181ea7821","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:34:39Z","timestamp":1786041279000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00045391-201009000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/mjt.0b013e3181ea7821","relation":{},"ISSN":["1075-2765"],"issn-type":[{"value":"1075-2765","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}